Scotia Capital Inc. Merck & Co., Inc. Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 316,783 shares of MRK stock, worth $31.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

316,783

Previous 283,783 11.63%

Holding current value

$31.2 Million

Previous $35.1 Million 2.39%

% of portfolio

0.2%

Previous 0.21%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$111.15 - $128.97 $3.67 Million - $4.26 Million	33,000 Added 11.63%	316,783 $36 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $3.32 Million - $3.57 Million	26,827 Added 10.44%	283,783 $35.1 Million
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $142,002 - $165,465	1,254 Added 0.49%	256,956 $33.9 Million
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $121,818 - $132,568	1,216 Added 0.48%	255,702 $27.9 Million
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $10 Million - $11.1 Million	-97,266 Reduced 27.65%	254,486 $26.2 Million
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $3.06 Million - $3.33 Million	-28,157 Reduced 7.41%	351,752 $40.6 Million
Q1 2023 May 11, 2023	SELL	$102.94 - $114.86 $4.35 Million - $4.85 Million	-42,210 Reduced 10.0%	379,909 $40.4 Million
Q4 2022 Feb 09, 2023	BUY	$87.44 - $112.11 $1.29 Million - $1.66 Million	14,763 Added 3.62%	422,119 $46.8 Million
Q3 2022 Nov 10, 2022	SELL	$84.53 - $94.96 $234,908 - $263,893	-2,779 Reduced 0.68%	407,356 $35.1 Million
Q2 2022 Aug 05, 2022	BUY	$83.49 - $94.64 $144,103 - $163,348	1,726 Added 0.42%	410,135 $37.4 Million
Q1 2022 May 09, 2022	BUY	$73.51 - $82.4 $459,952 - $515,576	6,257 Added 1.56%	408,409 $33.5 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $79,652 - $99,775	-1,102 Reduced 0.27%	402,152 $30.8 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $1.44 Million - $1.58 Million	-20,025 Reduced 4.73%	403,254 $30.3 Million
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $3.63 Million - $4.01 Million	51,610 Added 13.89%	423,279 $32.9 Million
Q1 2021 May 06, 2021	BUY	$68.86 - $81.11 $9.92 Million - $11.7 Million	144,053 Added 63.29%	371,669 $28.7 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $1.89 Million - $2.1 Million	-26,308 Reduced 10.36%	227,616 $18.6 Million
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $306,990 - $347,975	-4,195 Reduced 1.63%	253,924 $21.1 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $2.53 Million - $2.88 Million	35,896 Added 16.15%	258,119 $20 Million
Q1 2020 May 15, 2020	BUY	$63.36 - $87.82 $620,294 - $859,757	9,790 Added 4.61%	222,223 $17.1 Million
Q4 2019 Feb 13, 2020	BUY	$77.58 - $87.54 $1.3 Million - $1.47 Million	16,773 Added 8.57%	212,433 $19.3 Million
Q3 2019 Nov 14, 2019	BUY	$76.08 - $82.93 $2.65 Million - $2.89 Million	34,836 Added 21.66%	195,660 $16.5 Million
Q2 2019 Aug 13, 2019	SELL	$69.84 - $81.59 $232,846 - $272,021	-3,334 Reduced 2.03%	160,824 $13.5 Million
Q1 2019 May 15, 2019	SELL	$69.58 - $79.36 $586,768 - $669,242	-8,433 Reduced 4.89%	164,158 $13.7 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $22,116 - $25,665	339 Added 0.2%	172,591 $13.2 Million
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $618,148 - $726,905	-10,715 Reduced 5.86%	172,252 $12.2 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $207,589 - $243,896	4,084 Added 2.28%	182,967 $9.89 Million
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $465,570 - $541,125	9,136 Added 5.38%	178,883 $9.74 Million
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $55,956 - $66,817	-1,084 Reduced 0.63%	169,747 $9.55 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $167,385 - $180,109	-2,853 Reduced 1.64%	170,831 $10.9 Million
Q2 2017 Aug 15, 2017	BUY	N/A	173,684	173,684 $11.1 Million

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Merck & Co., Inc. Transaction History